What drug interactions should be monitored?

Antacids may reduce absorption; theophylline may increase toxicity; CYP450 inhibitors may increase side effects.

What is the composition of the solution?

Each 100 mL contains 500 mg Levofloxacin, 0.9% Sodium Chloride, and Water for Injection.

Levofloxacin Infusion

Name: Levofloxacin Infusion
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 1951944591

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.13

100,000 Bottle

Product profile

Customization

Available

Application

Intravenous Injection

Usage Mode

Intravenous Injection

Model NO.

500mg/100ml

Suitable for

Elderly, Children, Adult

State

Liquid

Shape

Solution

Type

Intravenous Injection

Pharmaceutical Technology

Chemical Synthesis

Transport Package

Carton

Specification

100ml

Trademark

SHIMEN

Origin

China

HS Code

3004909099

Production Capacity

1000000000/Year

Key features

Broad-Spectrum Antibiotic: Effective against gram-positive and gram-negative bacteria by inhibiting DNA gyrase.

Multiple Indications: Treats pneumonia, UTIs, skin infections, sinusitis, and intra-abdominal infections.

Sterile Nonpyrogenic Solution: Safe for intravenous use with 500mg Levofloxacin and 0.9% Sodium Chloride per 100mL.

GMP Certified Manufacturing: Produced under strict GMP requirements with full automation and international advanced technology.

Established Manufacturer: Shijiazhuang No.4 Pharmaceutical Co., Ltd. has 70 years of history and is a top 100 Chinese pharma enterprise.

Global Export Reach: Products exported to over 80 countries across Asia, Americas, Europe, Oceania, and Africa.

Single-Dose Packaging: Supplied in 100 mL single-dose containers to ensure sterility and precise dosing.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤18hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large, public pharmaceutical manufacturer based in Hebei, China. The company excels in producing infusion solutions and other pharmaceutical products, with advanced production lines and adherence to GMP standards. It holds ISO and GMP certifications, indicating a strong commitment to quality. The company has been exporting since 2002, with a portion of its sales derived from exports. It emphasizes innovation and customer satisfaction, with a growing reputation and numerous industry awards. However, specific details on financial credibility and customization capabilities are not fully disclosed.

Supplier typeShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large integrated pharmaceutical enterprise, engaging in manufacturing, R&D, and marketing.

CertificationsThe supplier holds ISO 9001, ISO 14001, and GMP certifications, indicating adherence to international management, environmental, and production standards.

After-Sales capabilityThe supplier emphasizes providing superior service concepts and measures, ensuring product quality and patient health.

R&D capabilityThe company integrates advanced technology into its production and emphasizes continuous improvement, indicating strong innovation capabilities.

Production capacityThe supplier has a large-scale production capacity with advanced lines for various pharmaceutical products, leading in the domestic market.